title: [Hepatic and hematological complications following ecstasy usage].
abstract: "Ecstasy" (3,4-Methylenedioxymethamphetamine), is used as a mood enhancer. We describe a case of a 23 year-old male suffering from thrombotic thrombocytopenic purpura (TTP), and severe hepatitis following ingestion of ecstasy. We describe the various hepatic complications, including hepatitis, cirrhosis, and hepatic failure, in addition to the hematological complications including DIC and TTP secondary to ecstasy abuse. Ecstasy abuse should be considered in every patient with unexplained hepatic or hematologic complications.
authors.affiliation: Liver Unit, Division of Medicine, Hadassah Ein-Kerem, Medical Center, Jerusalem.
authors.forename: O
authors.initials: O
authors.lastname: Shibolet
authors.forename: Y
authors.initials: Y
authors.lastname: Kalish
authors.forename: S
authors.initials: S
authors.lastname: Gillis
authors.forename: Y
authors.initials: Y
authors.lastname: Ilan
mesh_terms: D000328:Adult; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D006402:Hematologic Diseases / Q000139:chemically induced*; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced*; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced*; D019966:Substance-Related Disorders / Q000150:complications*
chemical_list: D018817:N-Methyl-3,4-methylenedioxyamphetamine